Tools
Tools
Marahatta, Sujan Babu, Yadav, Rajesh Kumar, Baral, Sushila, Aryal, Neeta, Paudel, Srijana, Shah, Naveen Prakash, Yadav, Punita, Gurung, Suman Chandra and Khatri, Elina (2021) 'Barriers to Treatment Compliance of Directly Observed Treatment Shortcourse among Pulmunary Tuberculosis Patients'. Journal of Nepal Health Research Council, Vol 19, Issue 3, pp. 450-459.
|
Text
J_Nepal_HRC_19_52_450-459.pdf - Published Version Available under License Creative Commons Attribution Non-commercial. Download (287kB) | Preview |
Abstract
Treatment compliance is an important aspect for tuberculosis prevention and control. Poor compliance to treatment can lead to the development of drug-resistant tuberculosis. The aim of this study was to explore the factors affecting treatment compliance for tuberculosis patients. Facility based unmatched case control study was done among the forty non-compliance and eighty compliance pulmonary tuberculosis patients registered at selected directly observed treatment short-course centers of six districts. Data were collected using in-depth interview guideline with the tuberculosis focal person and Focus Group Discussion with tuberculosis patients. A total of 120 respondents, 40 cases and 80 controls were enrolled in the study. About 72.5% of the cases and 56.2% of the controls were male. Five significant independent risk factors for non-compliance to TB treatment were identified. The qualitative session confirmed geographical barriers, inaccessibility to health facility, economic barriers, difficulty in convincing people, knowledge about Directly observed treatment shortcourse program, longer medication period, migration and stigma as a major barrier for treatment compliance. Wider ranges of barriers are prevalent in context of tuberculosis treatment pathway and outcome. Knowledge of the tuberculosis patients and attitude of the family plays a vital role in treatment compliance. Directly observed treatment shortcourse playing tremendous role to ensure treatment adherence has been identified as major barrier to adherence as well. Enablers of adherence need to be emphasized to address the barriers.
| Item Type: | Article |
|---|---|
| Subjects: | WF Respiratory System > WF 20 Research (General) WF Respiratory System > Tuberculosis > WF 200 Tuberculosis (General) WF Respiratory System > Tuberculosis > WF 300 Pulmonary tuberculosis WF Respiratory System > Tuberculosis > WF 310 Therapy |
| Faculty: Department: | Clinical Sciences & International Health > Clinical Sciences Department |
| Digital Object Identifer (DOI): | https://doi.org/10.33314/jnhrc.v19i3.3478 |
| SWORD Depositor: | JISC Pubrouter |
| Depositing User: | JISC Pubrouter |
| Date Deposited: | 07 Apr 2022 11:24 |
| Last Modified: | 20 Nov 2024 12:27 |
| URI: | https://archive.lstmed.ac.uk/id/eprint/20013 |
Statistics
Actions (login required)
 |
Edit Item |